Key Research Findings Summary

Discover the key preclinical findings regarding the human cathelicidin LL-37, focusing on toroidal pore formation, biofilm disruption, and FPRL1 signaling.

• LL-37 (Cathelicidin) research profile

≥99% purity, third-party COA verified, manufactured in the USA. For research use only — not for human or veterinary use.